Histogen Inc.
HSTO · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $3,769 | $919 | $2,059 | $11,454 |
| % Growth | 310.1% | -55.4% | -82% | – |
| Cost of Goods Sold | $0 | $220 | $968 | $2,215 |
| Gross Profit | $3,769 | $699 | $1,091 | $9,089 |
| % Margin | 100% | 76.1% | 53% | 79.4% |
| R&D Expenses | $5,021 | $8,473 | $6,219 | $4,095 |
| G&A Expenses | $9,391 | $7,796 | $6,586 | $6,213 |
| SG&A Expenses | $9,391 | $7,796 | $6,586 | $6,213 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$113 | $105 | -$150 |
| Operating Expenses | $14,412 | $16,156 | $19,949 | $10,158 |
| Operating Income | -$10,643 | -$15,457 | -$11,714 | -$12,006 |
| % Margin | -282.4% | -1,681.9% | -568.9% | -104.8% |
| Other Income/Exp. Net | -$1 | $448 | -$7,103 | -$1,932 |
| Pre-Tax Income | -$10,644 | -$15,009 | -$18,817 | -$11,385 |
| Tax Expense | $0 | $0 | $0 | $1,897 |
| Net Income | -$10,621 | -$14,950 | -$18,769 | -$11,385 |
| % Margin | -281.8% | -1,626.8% | -911.6% | -99.4% |
| EPS | -3.46 | -7.51 | -41.6 | -5.02 |
| % Growth | 53.9% | 81.9% | -728.7% | – |
| EPS Diluted | -3.46 | -7.51 | -41.6 | -5.02 |
| Weighted Avg Shares Out | 3,211 | 1,918 | 451 | 591 |
| Weighted Avg Shares Out Dil | 3,211 | 1,918 | 451 | 591 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $42 |
| Interest Expense | $1 | $10 | $64 | $0 |
| Depreciation & Amortization | $140 | $97 | $98 | $145 |
| EBITDA | -$10,503 | -$14,902 | -$18,655 | -$2,856 |
| % Margin | -278.7% | -1,621.5% | -906% | -24.9% |